The past, present, and future of monoclonal antibodies to IL-5 and eosinophilic asthma: a review

References

• AkinbamiLJMoormanJEBaileyCTrends in asthma prevalence, health care use, and mortality in the United States, 2001–2010NCHS Data Brief2012941822617340
   PubMedGoogle Scholar
• AkinbamiLJSullivanSDCampbellJDAsthma outcomes: healthcare utilization and costsJ Allergy Clin Immunol20121293 SupplS49S6422386509
   PubMed Web of Science ®Google Scholar
• BlackwellDLLJClarkeTCSummary health statistics for US adults: National Health Interview Survey, 2012. National Center for Health StatisticsVital Health Stat20142601161
   Google Scholar
• MooreWCMeyersDAWenzelSEIdentification of asthma phenotypes using cluster analysis in the Severe Asthma Research ProgramAm J Respir Crit Care Med2010181431532319892860
   PubMed Web of Science ®Google Scholar
• National Asthma Education and Prevention ProgramExpert panel report 3 (EPR-3): guidelines for the diagnosis and management of asthma-summary report 2007J Allergy Clin Immunol20071205 SupplS94S13817983880
   PubMed Web of Science ®Google Scholar
• NairPWhat is an “eosinophilic phenotype” of asthma?J Allergy Clin Immunol20131321818323727039
   PubMed Web of Science ®Google Scholar
• StoneKDPrussinCMetcalfeDDIgE, mast cells, basophils, and eosinophilsJ Allergy Clin Immunol20101252 Suppl 2S73S8020176269
   PubMed Web of Science ®Google Scholar
• RothenbergMEHoganSPThe eosinophilAnnu Rev Immunol20062414717416551246
   PubMed Web of Science ®Google Scholar
• ZhangJYWenzelSETissue and BAL based biomarkers in asthmaImmunol Allergy Clin North Am2007274623632vi17996580
   PubMed Web of Science ®Google Scholar
• BousquetJChanezPLacosteJYEosinophilic inflammation in asthmaN Engl J Med199032315103310392215562
   PubMed Web of Science ®Google Scholar
• WardlawAJBrightlingCEGreenRWoltmannGBraddingPPavordIDNew insights into the relationship between airway inflammation and asthmaClin Sci (Lond)2002103220121112149112
   PubMed Web of Science ®Google Scholar
• LeeJJJacobsenEAMcGarryMPSchleimerRPLeeNAEosinophils in health and disease: the LIAR hypothesisClin Exp Allergy201040456357520447076
   PubMed Web of Science ®Google Scholar
• Nissim Ben EfraimAHLevi-SchafferFTissue remodeling and angiogenesis in asthma: the role of the eosinophilTher Adv Respir Dis20082316317119124368
   PubMedGoogle Scholar
• WenzelSESchwartzLBLangmackELEvidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristicsAm J Respir Crit Care Med199916031001100810471631
   PubMed Web of Science ®Google Scholar
• WoodruffPGModrekBChoyDFT-helper type 2-driven inflammation defines major subphenotypes of asthmaAm J Respir Crit Care Med2009180538839519483109
   PubMed Web of Science ®Google Scholar
• ChungKFWenzelSEBrozekJLInternational ERS/ATS guidelines on definition, evaluation and treatment of severe asthmaEur Respir J201443234337324337046
   PubMed Web of Science ®Google Scholar
• WenzelSSevere asthma in adultsAm J Respir Crit Care Med2005172214916015849323
   PubMed Web of Science ®Google Scholar
• SehmiRWardlawAJCromwellOKuriharaKWaltmannPKayABInterleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjectsBlood19927911295229591316789
   PubMed Web of Science ®Google Scholar
• GarciaGTailleCLavenezianaPBourdinAChanezPHumbertMAnti-interleukin-5 therapy in severe asthmaEur Respir Rev20132212925125723997052
   PubMedGoogle Scholar
• GleichGJMechanisms of eosinophil-associated inflammationJ Allergy Clin Immunol2000105465166310756213
   PubMed Web of Science ®Google Scholar
• YamaguchiYSudaTSudaJPurified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursorsJ Exp Med1988167143563257253
   PubMed Web of Science ®Google Scholar
• FosterPSHoganSPRamsayAJMatthaeiKIYoungIGInterleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma modelJ Exp Med199618311952018551223
   PubMed Web of Science ®Google Scholar
• LeeJJMcGarryMPFarmerSCInterleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthmaJ Exp Med199718512214321569182686
   PubMed Web of Science ®Google Scholar
• HamidQAzzawiMYingSExpression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthmaJ Clin Invest1991875154115462022726
   PubMed Web of Science ®Google Scholar
• HumbertMCorriganCJKimmittPTillSJKayABDurhamSRRelationship between IL-4 and IL-5 mRNA expression and disease severity in atopic asthmaAm J Respir Crit Care Med19971563 Pt 17047089309982
   PubMed Web of Science ®Google Scholar
• LamblinCGossetPSalezFEosinophilic airway inflammation in nasal polyposisJ Allergy Clin Immunol19991041859210400844
   PubMed Web of Science ®Google Scholar
• RobinsonDHamidQBentleyAYingSKayABDurhamSRActivation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthmaJ Allergy Clin Immunol19939223133248349942
   PubMed Web of Science ®Google Scholar
• RobinsonDSYingSBentleyAMRelationships among numbers of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine responsiveness in atopic asthmaJ Allergy Clin Immunol19939233974038360390
   PubMed Web of Science ®Google Scholar
• ShiHZXiaoCQZhongDEffect of inhaled interleukin-5 on airway hyperreactivity and eosinophilia in asthmaticsAm J Respir Crit Care Med199815712042099445301
   PubMed Web of Science ®Google Scholar
• LeckieMJten BrinkeAKhanJEffects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic responseLancet200035692482144214811191542
   PubMed Web of Science ®Google Scholar
• Flood-PagePSwensonCFaifermanIA study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthmaAm J Respir Crit Care Med2007176111062107117872493
   PubMed Web of Science ®Google Scholar
• NairPPizzichiniMMKjarsgaardMMepolizumab for prednisone-dependent asthma with sputum eosinophiliaN Engl J Med20093601098599319264687
   PubMed Web of Science ®Google Scholar
• Flood-PagePMenzies-GowAPhippsSAnti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmaticsJ Clin Invest200311271029103614523040
   PubMed Web of Science ®Google Scholar
• HaldarPBrightlingCEHargadonBMepolizumab and exacerbations of refractory eosinophilic asthmaN Engl J Med20093601097398419264686
   PubMed Web of Science ®Google Scholar
• EsnaultSKellyEAShenZJJohanssonMWMalterJSJarjourNNIL-3 maintains activation of the p90S6K/RPS6 pathway and increases translation in human eosinophilsJ Immunol201519562529253926276876
   PubMed Web of Science ®Google Scholar
• EsnaultSMalterJSGranulocyte macrophage-colony-stimulating factor mRNA is stabilized in airway eosinophils and peripheral blood eosinophils activated by TNF-alpha plus fibronectinJ Immunol200116674658466311254725
   PubMed Web of Science ®Google Scholar
• PavordIDKornSHowarthPMepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trialLancet2012380984265165922901886
   PubMed Web of Science ®Google Scholar
• OrtegaHGLiuMCPavordIDMepolizumab treatment in patients with severe eosinophilic asthmaN Engl J Med2014371131198120725199059
   PubMed Web of Science ®Google Scholar
• BelEHWenzelSEThompsonPJOral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthmaN Engl J Med2014371131189119725199060
   PubMed Web of Science ®Google Scholar
• CastroMMathurSHargreaveFReslizumab for poorly controlled, eosinophilic asthma: a randomized, placebo-controlled studyAm J Respir Crit Care Med2011184101125113221852542
   PubMed Web of Science ®Google Scholar
• KipsJCO’ConnorBJLangleySJEffect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot studyAm J Respir Crit Care Med2003167121655165912649124
   PubMed Web of Science ®Google Scholar
• BatemanNDShahiAFeeleyKMWoolfordTJActivated eosinophils in nasal polyps: a comparison of asthmatic and non-asthmatic patientsClin Otolaryngol200530322122516111416
   PubMed Web of Science ®Google Scholar
• GevaertPLang-LoidoltDLacknerANasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polypsJ Allergy Clin Immunol200611851133114117088140
   PubMed Web of Science ®Google Scholar
• BjermerCLMasperoJorgeCiesielskaMonikaO’BrienChristopherZangrilliJamesA randomized phase 3 study of the efficacy and safety of reslizumab in subjects with asthma with elevated eosinophilsEuropean Respiratory Journal2014445829925082909
   PubMed Web of Science ®Google Scholar
• GhaziATrikhaACalhounWJBenralizumab – a humanized mAb to IL-5Ralpha with enhanced antibody-dependent cell-mediated cytotoxicity – a novel approach for the treatment of asthmaExpert Opin Biol Ther201212111311822136436
   PubMed Web of Science ®Google Scholar
• CastroMWenzelSEBleeckerERBenralizumab, an anti-interleukin 5 receptor alpha monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging studyLancet Respir Med201421187989025306557
   PubMed Web of Science ®Google Scholar
• JatakanonALimSKharitonovSAChungKFBarnesPJCorrelation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthmaThorax199853291959624291
   PubMed Web of Science ®Google Scholar
• SchleichFNSeidelLSeleJExhaled nitric oxide thresholds associated with a sputum eosinophil count >/=3% in a cohort of unselected patients with asthmaThorax201065121039104420671307
   PubMed Web of Science ®Google Scholar
• WesterhofGAKorevaarDAAmelinkMBiomarkers to identify sputum eosinophilia in different adult asthma phenotypesEur Respir J201546368869626113672
   PubMed Web of Science ®Google Scholar
• WagenerAHde NijsSBLutterRExternal validation of blood eosinophils, FE(NO) and serum periostin as surrogates for sputum eosinophils in asthmaThorax201570211512025422384
   PubMed Web of Science ®Google Scholar
• JiaGEricksonRWChoyDFPeriostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patientsJ Allergy Clin Immunol20121303647654.e1022857879
   PubMed Web of Science ®Google Scholar